Detalhe da pesquisa
1.
Covid-19 Vaccine Protection among Children and Adolescents in Qatar.
N Engl J Med
; 387(20): 1865-1876, 2022 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322837
2.
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
N Engl J Med
; 386(19): 1804-1816, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263534
3.
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
N Engl J Med
; 387(1): 21-34, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35704396
4.
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
N Engl J Med
; 385(24): e83, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614327
5.
Estimating protection afforded by prior infection in preventing reinfection: Applying the test-negative study design.
Am J Epidemiol
; 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38061757
6.
Seroprevalence of herpes simplex virus type 1 and type 2 among the migrant workers in Qatar.
Virol J
; 20(1): 188, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37608372
7.
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant.
Clin Infect Dis
; 75(1): e1188-e1191, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34657152
8.
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
Clin Infect Dis
; 73(7): e1830-e1840, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33315061
9.
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar.
Emerg Infect Dis
; 27(5): 1343-1352, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33900174
10.
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
PLoS Med
; 18(12): e1003879, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914711
11.
Protection against Reinfection with the Omicron BA.2.75 Subvariant.
N Engl J Med
; 388(7): 665-667, 2023 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652342
12.
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
JAMA
; 326(19): 1930-1939, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724027
13.
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants.
N Engl J Med
; 387(17): 1620-1622, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36198139
14.
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.
N Engl J Med
; 386(13): 1288-1290, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35139269
15.
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2.
N Engl J Med
; 387(18): 1716-1718, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223534
16.
Associations of Vaccination and of Prior Infection With Positive PCR Test Results for SARS-CoV-2 in Airline Passengers Arriving in Qatar.
JAMA
; 326(2): 185-188, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34106201
17.
The state of health in the Arab world, 1990-2010: an analysis of the burden of diseases, injuries, and risk factors.
Lancet
; 383(9914): 309-20, 2014 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452042
18.
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
Front Med (Lausanne)
; 11: 1363045, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529118
19.
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
J Travel Med
; 2024 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38591115
20.
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Vaccine
; 42(14): 3307-3320, 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38616439